To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 616.00 |
Bid | 608.00 |
Ask | 616.00 |
Change | 10.00 (1.65%) |
Volume | 19,950 |
Open | 612.00 |
High | 616.00 |
Low | 612.00 |
Prev. Close | 606.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.75m |
Market Capitalisation | £232.56m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 40 |
---|---|
Vol. Sold | 8,034 |
Sold Value | £48.91k |
Vol. Bought | 6,300 |
Bought Value | £38.49k |
PE Ratio | 36.68851 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.578% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 17:51:28 | 610.00 | 400 | Unknown* | 608.00 | 616.00 | 2,440 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:35:17 | 616.00 | 15 | Buy* | 608.00 | 616.00 | 92.40 | UT Uncrossing Trade |
26-Apr-24 | 16:25:51 | 615.04 | 3 | Buy* | 608.00 | 616.00 | 18.45 | O Ordinary |
26-Apr-24 | 16:13:35 | 615.04 | 32 | Buy* | 608.00 | 616.00 | 196.81 | O Ordinary |
26-Apr-24 | 16:11:52 | 612.2175 | 996 | Sell* | 608.00 | 618.00 | 6,098 | O Ordinary |
26-Apr-24 | 16:01:44 | 612.00 | 600 | Buy* | 608.00 | 612.00 | 3,672 | A Automatic Execution |
26-Apr-24 | 15:49:17 | 611.518 | 410 | Buy* | 608.00 | 612.00 | 2,507 | O Ordinary |
26-Apr-24 | 15:35:39 | 609.683 | 1,500 | Sell* | 608.00 | 612.00 | 9,145 | O Ordinary |
26-Apr-24 | 15:08:47 | 609.6815 | 271 | Sell* | 608.00 | 612.00 | 1,652 | O Ordinary |
26-Apr-24 | 15:00:34 | 608.5163 | 1,586 | Sell* | 606.00 | 612.00 | 9,651 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |